IRIS International, Inc. manufactures in vitro diagnostic (IVD) products for urinalysis and body fluids. The companys IVD segment offers iQ analyzer, an automated urine microscopy and body fluids analyzer; iQ Body Fluids Module; Optional iWare Software; iChem VELOCITY and iRICELL, an automated urine chemistry analyzer; 3GEMS Urinalysis and Body Fluids; and 3GEMS Hematology, a blood count analyzer. This segment also provides consumables for microscopy systems, test strips, calibrators, controls, and urine chemistry analyzers. Its Sample Processing segment offers benchtop centrifuges, small instruments, and supplies used for applications in coagulation, cytology, hematology, urinalysis, and DNA processing. This segment provides Express centrifuge line for clinical diagnostic market; ThermoBrite, a DNA workstation for FISH procedures; Cytofuge 2, a centrifuge for layer cell preparation; Cytofuge 12, a 12 placement centrifuge used for thin layer cell preparation; IDEXX Drive and IDEXX whole blood separator for use in IDEXX chemistry analyzers; and OvaTube, an ova and parasite testing for veterinarian market. The companys Personalized Medicine segment offers oncology and molecular diagnostics services. This segments products include Arista Molecular Tests for the diagnosis and prognostication of pathologic entities; Flow cytometry, a cell analysis platform; FISH for the detection of DNA on chromosomes; NADiA ProsVue used in prognostication of patients; NADiA HIV to monitor HIV viral load; and NADiA CECs for the detection of circulating epithelial cells. It serves medical institutions, commercial laboratories, clinics, doctors offices, veterinary laboratories, and research facilities. IRIS International sells its products through a direct sales and service force in the United States, as well as through distributors internationally. The company was founded in 1979 and is headquartered in Chatsworth, California.